PubPeer
The online Journal club
login
create account
Home
Publications
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial
Vaccine (2022) -
Comments
pubmed: 35501178 doi: 10.1016/j.vaccine.2022.04.035 issn: 0264-410x issn: 1873-2518
Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P Schuring, Mitsuhiro Mori
Go to article
Go to preprint
Elsevier BV
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})